Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/57548
Conference/Presentation Title: G.P.13.07 Prevalence and diagnosis of sporadic inclusion body myositis (sIBM) in Western Australia.
Authors: Needham M.;Corbett A.;Day T.;Fabian V.;Mastaglia F.
Institution: (Needham) ANRI, Perth,ANRI, Perth, Australia
(Corbett) Concord Repatriation Hospital, Sydney, Australia
(Day) Monash Medical Centre, Melbourne, Australia
(Fabian) Royal Perth Hospital, Section of Neuropathology, Perth, Australia
(Mastaglia) Australian Neuromuscular Research Institute, Perth, Australia
Presentation/Conference Date: 9-Mar-2026
Copyright year: 2007
Publisher: Elsevier Ltd
Publication information: Neuromuscular Disorders. Conference: 12th International Congress of the World Muscle Society Giardini Naxos. Taormina Italy. 17(9-10) (pp 850-851), 2007. Date of Publication: 01 Oct 2007.
Journal: Neuromuscular Disorders
Abstract: The prevalence of sIBM is known to vary in different populations. Published figures vary from 4.9 x 10-6 to 10.7 x 10-6. A prevalence study in Western Australia (WA) in 2000, found a prevalence of 9.3 X10-6, with an age-adjusted figure of 35.3 X10-6 over 50 years of age. We have undertaken a follow-up survey to determine whether there has been a change in prevalence over the ensuing 6 year period. In addition, a cohort of 57 biopsy-proven sIBM patients has been reviewed to ascertain the average delay in establishing the diagnosis and frequency of misdiagnosis of the condition. All new cases of biopsy-proven sIBM since the previous survey were ascertained from the records of the Neuromuscular Clinic at the ANRI, from hospital pathology departments, and with a questionnaire to all neurologists and rheumatologists. Only patients with definite or probable sIBM were accepted for the survey. Population statistics for the state of WA were obtained from the Australian Bureau of Statistics as at September 2006. The current prevalence figure was found to be 13 X10-6, with an age-adjusted prevalence of 39.5 X10-6 over the age of 50 years, and a male-to-female ratio of 1.4:1. The mean delay from symptom onset to diagnosis was 5.2 years. This was partly accounted for by a delay in seeking medical attention (mean 2.9 years), and by initial misdiagnosis of the condition in 52.7% of patients. The initial diagnoses in this subgroup of patients included arthritis, motor neuron disease, polymyositis and 'old age'. These findings indicate that there has been only a slight increase in prevalence since the previous survey, most likely reflecting improved case ascertainment. However, there is still a considerable delay in the time to diagnosis and a high rate of initial misdiagnosis indicating that the condition is still not well recognised, and that there is a need to increase the level of awareness of sIBM among the medical community.Copyright © 2007
Conference Name: 12th International Congress of the World Muscle Society Giardini Naxos
Conference Start Date: 2007-10-17
Conference End Date: 2007-10-20
Conference Location: Taormina, Italy
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.nmd.2007.06.299
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/57548
Type: Conference Abstract
Subjects: arthritis awareness diagnostic error epidemiology motor neuron disease neurologist polymyositis rheumatologist sporadic inclusion body myositis Western Australia
Appears in Collections:Conference Abstracts

Show full item record

Page view(s)

74
checked on May 26, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.